About this trial
This randomized controlled clinical trial aims to evaluate the effectiveness of dual-task training on cognitive functions in patients with Alzheimer's disease. Participants will be randomly assigned to either a dual-task training group or a conventional exercise group. The intervention will last 8 weeks, with three supervised sessions per week. Cognitive performance, mobility, balance, and quality of life will be assessed before and after the intervention.
Eligibility criteria
Qualifiers
Age ≥ 60 years
Diagnosed with mild-stage Alzheimer's disease (According to DSM-5 or NINCDS-ADRDA criteria)
MoCA score between 10-25 (Indicating sufficient cognitive capacity for dual-task training)
Ability to walk independently or with minimal assistance
Disqualifiers
Diagnosis of advanced-stage Alzheimer's disease (MoCA < 10)
Presence of additional neurological disorders affecting the motor system (e.g. Parkinson's disease, stroke, multiple sclerosis)
Severe hearing or vision impairment (inability to respond to visual or auditory stimuli)
History of psychiatric disorders (e.g., major depression, schizophrenia)
Trial design
Treatments tested in this trial
- Dual-Task Motor-Cognitive Training
- Conventional Exercise Training